Page last updated: 2024-10-24

chlorambucil and Pyoderma

chlorambucil has been researched along with Pyoderma in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Pyoderma: Any purulent skin disease (Dorland, 27th ed).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callen, JP1
Case, JD1
Sager, D1
Najmowicz-Dabrowa, H1

Other Studies

2 other studies available for chlorambucil and Pyoderma

ArticleYear
Chlorambucil--an effective corticosteroid-sparing therapy for pyoderma gangrenosum.
    Journal of the American Academy of Dermatology, 1989, Volume: 21, Issue:3 Pt 1

    Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Chlorambucil; Gangrene; Humans; Leg Ulcer; Mal

1989
[Serious infectious complications of chronic lymphatic leukemia].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1974, Oct-01, Volume: 27, Issue:19

    Topics: Chlorambucil; Chronic Disease; Female; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Middle

1974